Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Interplay of PhoP and DevR response regulators defines expression of the dormancy regulon in virulent Mycobacterium tuberculosis.

Vashist A, Malhotra V, Sharma G, Tyagi JS, Clark-Curtiss JE.

J Biol Chem. 2018 Oct 19;293(42):16413-16425. doi: 10.1074/jbc.RA118.004331. Epub 2018 Sep 4.

PMID:
30181216
2.

Salmonella Vaccines: Conduits for Protective Antigens.

Clark-Curtiss JE, Curtiss R 3rd.

J Immunol. 2018 Jan 1;200(1):39-48. doi: 10.4049/jimmunol.1600608. Review.

3.

Erratum to: The Mycobacterium tuberculosis relBE toxin: antitoxin genes are stress-responsive modules that regulate growth through translation inhibition.

Korch SB, Malhotra V, Contreras H, Clark-Curtiss JE.

J Microbiol. 2015 Dec;53(12):875. doi: 10.1007/s12275-015-0741-3. No abstract available.

PMID:
26626358
4.

The Mycobacterium tuberculosis relBE toxin:antitoxin genes are stress-responsive modules that regulate growth through translation inhibition.

Korch SB, Malhotra V, Contreras H, Clark-Curtiss JE.

J Microbiol. 2015 Nov;53(11):783-95. doi: 10.1007/s12275-015-5333-8. Epub 2015 Oct 28. Erratum in: J Microbiol. 2015 Dec;53(12):875.

5.

Mycobacterium tuberculosis response regulators, DevR and NarL, interact in vivo and co-regulate gene expression during aerobic nitrate metabolism.

Malhotra V, Agrawal R, Duncan TR, Saini DK, Clark-Curtiss JE.

J Biol Chem. 2015 Mar 27;290(13):8294-309. doi: 10.1074/jbc.M114.591800. Epub 2015 Feb 6.

6.

Mycobacterium tuberculosis protein kinase K enables growth adaptation through translation control.

Malhotra V, Okon BP, Clark-Curtiss JE.

J Bacteriol. 2012 Aug;194(16):4184-96. doi: 10.1128/JB.00585-12. Epub 2012 Jun 1.

7.

Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.

Juárez-Rodríguez MD, Arteaga-Cortés LT, Kader R, Curtiss R 3rd, Clark-Curtiss JE.

Infect Immun. 2012 Feb;80(2):798-814. doi: 10.1128/IAI.05525-11. Epub 2011 Dec 5.

8.

Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.

Juárez-Rodríguez MD, Yang J, Kader R, Alamuri P, Curtiss R 3rd, Clark-Curtiss JE.

Infect Immun. 2012 Feb;80(2):815-31. doi: 10.1128/IAI.05526-11. Epub 2011 Dec 5.

9.

The prrAB two-component system is essential for Mycobacterium tuberculosis viability and is induced under nitrogen-limiting conditions.

Haydel SE, Malhotra V, Cornelison GL, Clark-Curtiss JE.

J Bacteriol. 2012 Jan;194(2):354-61. doi: 10.1128/JB.06258-11. Epub 2011 Nov 11.

10.

Mycobacterium tuberculosis protein kinase K confers survival advantage during early infection in mice and regulates growth in culture and during persistent infection: implications for immune modulation.

Malhotra V, Arteaga-Cortés LT, Clay G, Clark-Curtiss JE.

Microbiology. 2010 Sep;156(Pt 9):2829-41. doi: 10.1099/mic.0.040675-0. Epub 2010 Jun 3.

11.

DevR-mediated adaptive response in Mycobacterium tuberculosis H37Ra: links to asparagine metabolism.

Malhotra V, Tyagi JS, Clark-Curtiss JE.

Tuberculosis (Edinb). 2009 Mar;89(2):169-74. doi: 10.1016/j.tube.2008.12.003. Epub 2009 Feb 13.

12.

Three Mycobacterium tuberculosis Rel toxin-antitoxin modules inhibit mycobacterial growth and are expressed in infected human macrophages.

Korch SB, Contreras H, Clark-Curtiss JE.

J Bacteriol. 2009 Mar;191(5):1618-30. doi: 10.1128/JB.01318-08. Epub 2008 Dec 29.

14.
15.

Molecular genetics of Mycobacterium tuberculosis pathogenesis.

Clark-Curtiss JE, Haydel SE.

Annu Rev Microbiol. 2003;57:517-49. Review.

PMID:
14527290
16.

Microbial gene expression elucidated by selective capture of transcribed sequences (SCOTS).

Daigle F, Hou JY, Clark-Curtiss JE.

Methods Enzymol. 2002;358:108-22. No abstract available.

PMID:
12474381
17.
18.

Expression, autoregulation, and DNA binding properties of the Mycobacterium tuberculosis TrcR response regulator.

Haydel SE, Benjamin WH Jr, Dunlap NE, Clark-Curtiss JE.

J Bacteriol. 2002 Apr;184(8):2192-203.

19.

Identifying mycobacterium tuberculosis virulence determinants - new technologies for a difficult problem: response

Graham JE, Clark-Curtiss JE.

Trends Microbiol. 2000 Mar;8(3):100. No abstract available.

PMID:
10707057
21.

Identification of virulence determinants in pathogenic mycobacteria.

Clark-Curtiss JE.

Curr Top Microbiol Immunol. 1998;225:57-79. Review. No abstract available.

PMID:
9386328
22.
23.

Immunological and functional characterization of Mycobacterium leprae protein antigens: an overview.

Thole JE, Wieles B, Clark-Curtiss JE, Ottenhoff TH, Rinke de Wit TF.

Mol Microbiol. 1995 Dec;18(5):791-800. Review.

PMID:
8825083
24.

A Mycobacterium leprae gene encoding a fibronectin binding protein is used for efficient invasion of epithelial cells and Schwann cells.

Schorey JS, Li Q, McCourt DW, Bong-Mastek M, Clark-Curtiss JE, Ratliff TL, Brown EJ.

Infect Immun. 1995 Jul;63(7):2652-7.

25.

Leprosy vaccine.

Bloom BR, Jacobs WR Jr, Clark-Curtiss JE.

Nature. 1994 Apr 14;368(6472):579. No abstract available.

PMID:
7908414
26.
27.

A Mycobacterium leprae-specific gene encoding an immunologically recognized 45 kDa protein.

Rinke de Wit TF, Clark-Curtiss JE, Abebe F, Kolk AH, Janson AA, van Agterveld M, Thole JE.

Mol Microbiol. 1993 Nov;10(4):829-38.

PMID:
7934845
28.

Detection of genes expressed by Mycobacterium avium growing in human macrophages.

Plum G, Clark-Curtiss JE.

Infect Agents Dis. 1993 Aug;2(4):279-81. No abstract available.

PMID:
8173810
30.

Molecular and immunological analysis of a fibronectin-binding protein antigen secreted by Mycobacterium leprae.

Thole JE, Schöningh R, Janson AA, Garbe T, Cornelisse YE, Clark-Curtiss JE, Kolk AH, Ottenhoff TH, De Vries RR, Abou-Zeid C.

Mol Microbiol. 1992 Jan;6(2):153-63.

PMID:
1532043
31.

Localization of the steroid 1-dehydrogenase in Rhodococcus erythropolis IMET 7030 by immunoelectron microscopy.

Wagner B, Atrat PG, Clark-Curtiss JE, Wagner M.

J Basic Microbiol. 1992;32(1):65-71.

PMID:
1527710
34.
35.

Protein antigens of Mycobacterium leprae.

Clark-Curtiss JE, Thole JE, Sathish M, Bosecker BA, Sela S, de Carvalho EF, Esser RE.

Res Microbiol. 1990 Sep-Oct;141(7-8):859-71.

PMID:
2101476
36.
37.

Conservation of genomic sequences among isolates of Mycobacterium leprae.

Clark-Curtiss JE, Walsh GP.

J Bacteriol. 1989 Sep;171(9):4844-51.

39.

Characterization and taxonomic implications of the rRNA genes of Mycobacterium leprae.

Sela S, Clark-Curtiss JE, Bercovier H.

J Bacteriol. 1989 Jan;171(1):70-3.

40.

A species-specific repetitive sequence in Mycobacterium leprae DNA.

Clark-Curtiss JE, Docherty MA.

J Infect Dis. 1989 Jan;159(1):7-15.

PMID:
2642523
41.

Benefits of recombinant DNA technology for the study of Mycobacterium leprae.

Clark-Curtiss JE.

Curr Top Microbiol Immunol. 1988;138:61-79. Review. No abstract available.

PMID:
3058391
42.
43.

Expression of Mycobacterium leprae genes from a Streptococcus mutans promoter in Escherichia coli K-12.

Jacobs WR, Docherty MA, Curtiss R 3rd, Clark-Curtiss JE.

Proc Natl Acad Sci U S A. 1986 Mar;83(6):1926-30.

44.

Molecular analysis of DNA and construction of genomic libraries of Mycobacterium leprae.

Clark-Curtiss JE, Jacobs WR, Docherty MA, Ritchie LR, Curtiss R 3rd.

J Bacteriol. 1985 Mar;161(3):1093-102.

45.

Analysis of recombinant DNA using Escherichia coli minicells.

Clark-Curtiss JE, Curtiss R 3rd.

Methods Enzymol. 1983;101:347-62. No abstract available.

PMID:
6350817

Supplemental Content

Loading ...
Support Center